Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
5
×
life sciences
national blog main
5
×
national top stories
boston blog main
boston top stories
fda
new york blog main
boston
medical devices
new york
new york top stories
roche
san francisco blog main
alex gorsky
alirocumab
alnylam pharmaceuticals
amgen
ashley mcevoy
auris health
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
detroit
detroit blog main
detroit top stories
duchenne
europe blog main
europe top stories
evolocumab
foundation medicine
foundationone cdx
foundationone heme
frederic moll
genentech
What
billion
5
×
deal
acquire
cash
agreed
fda
medical
medicine
recently
roche
acquiring
adds
approval
auris
betting
big
biopharma
brings
broad
builds
buy
cholesterol
company
company’s
compound
confidence
developer
device
didn’t
drug
duchenne
extremities
foundation
gain
gene
genentech
giant
health
historic
johnson
Language
unset
Current search:
deals
×
billion
×
" national blog main "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine